SCHEMBL6618636

SCHEMBL6618636

CCOc1ccc(-c2cnc3cc4[nH]ncc4cc3n2)cc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR2 P21802 5/20 0.56
▸ FGFR1 P11362 4/20 0.51
▸ MAPK1 P28482 1/20 0.43
▸ TRPA1 O75762 1/20 0.43
▸ FGFR3 P22607 1/20 0.42
▸ PDGFRB P09619 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ APAF1 O14727 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MAP3K11 Q16584 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ JAK2 O60674 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ PAK4 O96013 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6615661 1.00 FGFR2 (0.56) FGFR2FGFR1MAPK1TRPA1FGFR3
SCHEMBL9052838 0.91 FGFR2 (0.48) FGFR2FGFR1MAPK1TRPA1FGFR3
SCHEMBL6618595 0.89 PDGFRB (0.51) FGFR2FGFR1MAPK1PDGFRBPDGFRA
SCHEMBL6616842 0.89 PDGFRB (0.51) FGFR2FGFR1MAPK1PDGFRBPDGFRA
SCHEMBL9133723 0.89 PDGFRB (0.51) FGFR2FGFR1MAPK1PDGFRBPDGFRA
SCHEMBL8102827 0.80 FGFR2 (0.39) FGFR2FGFR1MAPTKDM4EALDH1A1
SCHEMBL6618763 0.80 MAP3K11 (0.55) MAPK1PDGFRBPDGFRAMAPTKDM4E
SCHEMBL6618374 0.80 MAP3K11 (0.55) MAPK1PDGFRBPDGFRAMAPTKDM4E
SCHEMBL6617504 0.80 FGFR2 (0.65) FGFR2FGFR1MAPK1TRPA1FGFR3
SCHEMBL8116664 0.80 FGFR2 (0.65) FGFR2FGFR1MAPK1TRPA1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback